GL1X · GenesisL1 explorer

MolNFT v1 · #86447 · protein

Aminoimidazoles as bace-1 inhibitors: from de novo design to ab-lowering in brain

4B70 · Beta-secretase 1: “Aminoimidazoles as bace-1 inhibitors: from de novo design to ab-lowering in brain”. X-ray diffraction, 1 ligand (WM9), 3 pockets (best druggability 0.66). MolNFT v1 #86447 on GenesisL1: 3D structure, binding sites…

PDB
4B70
Type
protein
Length
372 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-secretase 1
EC
3.4.23.46
UniProt
P56817
Ligands
WM9
Pockets
3 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 15% helix, 42% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-secretase 1 (EC 3.4.23.46)protein37215% helix, 42% strandP56817

Ligands and binding sites

  • WM9 · (2S)-2-[3-(3-chlorophenyl)phenyl]-2-methyl-5,6-dihydro-1,3-oxazin-4-amine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15850.660.7647WM9
21240.440.7725empty
3550.280.7417empty

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 4B70 · Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in Brain · the same entry in another collection · chain A against A, TM-score 1.00
  • P56817 · AlphaFold monomer V2.0 prediction for beta-secretase 1 (P56817) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.